CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure.
about
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewRituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphomaSynergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma.Inotuzumab ozogamicin as novel therapy in lymphomas.Single nucleotide polymorphisms of CD20 gene and their relationship with clinical efficacy of R-CHOP in patients with diffuse large B cell lymphoma.Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention.New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.Inotuzumab ozogamicin in the treatment of B-cell acute lymphoblastic leukemia.Construction and characterization of a camelized, human, VH-based peptide vaccine against CD20 antigen.CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.Rituximab for the treatment of follicular lymphoma.Early relapse in a case of primary bone marrow diffuse large B-cell lymphoma treated with rituximab-CHOP.The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations.Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties.
P2860
Q27304386-DDFB2B88-540C-4074-A8F9-5DEE14C98281Q33599174-CF77BA34-4917-4390-891C-AE97C43F288EQ34104112-41B4AAF0-B31C-424F-A1EE-A6334308FF20Q34620271-A785CB62-B0D3-483E-A1AF-DBB52439499DQ36940760-042DF16C-0A67-4DA8-84F1-23F69CCDCCAFQ37448352-455B89A3-8B30-4636-AA6E-F77C999C4897Q37716643-B8C69F4F-00BB-4632-8BD4-0DA8343AE456Q38002447-DEA86660-F674-46FE-89CF-EFF0CCF4C071Q39193766-E9D38DA3-B999-43E5-9312-1729D7C5FB7BQ39313119-D8448709-0154-4007-995C-A4870A40FCD1Q39360775-72C51E13-C1E9-43F2-B841-1EDE4759AB21Q40063229-0B11C5BC-EA53-4C12-8665-506FE412EAAAQ40297342-3FE48337-AC6E-44BF-B852-8B51896F6614Q41966195-6F04469F-8800-4F85-A986-DA3ED86947DF
P2860
CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD20 mutations involving the r ...... icant cause of R-CHOP failure.
@en
CD20 mutations involving the r ...... icant cause of R-CHOP failure.
@nl
type
label
CD20 mutations involving the r ...... icant cause of R-CHOP failure.
@en
CD20 mutations involving the r ...... icant cause of R-CHOP failure.
@nl
prefLabel
CD20 mutations involving the r ...... icant cause of R-CHOP failure.
@en
CD20 mutations involving the r ...... icant cause of R-CHOP failure.
@nl
P2093
P2860
P50
P1433
P1476
CD20 mutations involving the r ...... icant cause of R-CHOP failure.
@en
P2093
Ali Bashashati
Bruce Woolcock
Laurie H Sehn
Mukesh Chhanabhai
Nathalie A Johnson
Ronald J deLeeuw
Stephen Leach
P2860
P304
P356
10.3324/HAEMATOL.2008.001024
P577
2009-02-11T00:00:00Z